Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.

Wyatt RC, Brigatti C, Grace SL, Williams CL, Marzinotto I, Gillard BT, Bazzigaluppi E, Shoemark D, Chandler MA, Achenbach P, Piemonti L, BOX Study Group, AWAF, Gillespie KM, Lampasona V, Williams AJK, Long AE

Open source

DOI: 10.1111/dme.70277
Published: 2026 Aug
Container: Diabetic medicine : a journal of the British Diabetic Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dme.70277,
  title = {Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.},
  author = {Wyatt RC and Brigatti C and Grace SL and Williams CL and Marzinotto I and Gillard BT and Bazzigaluppi E and Shoemark D and Chandler MA and Achenbach P and Piemonti L and BOX Study Group and AWAF and Gillespie KM and Lampasona V and Williams AJK and Long AE},
  year = {2026},
  journal = {Diabetic medicine : a journal of the British Diabetic Association},
  doi = {10.1111/dme.70277},
  url = {https://doi.org/10.1111/dme.70277}
}

RIS

TY  - JOUR
TI  - Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.
AU  - Wyatt RC
AU  - Brigatti C
AU  - Grace SL
AU  - Williams CL
AU  - Marzinotto I
AU  - Gillard BT
AU  - Bazzigaluppi E
AU  - Shoemark D
AU  - Chandler MA
AU  - Achenbach P
AU  - Piemonti L
AU  - BOX Study Group
AU  - AWAF
AU  - Gillespie KM
AU  - Lampasona V
AU  - Williams AJK
AU  - Long AE
PY  - 2026
JO  - Diabetic medicine : a journal of the British Diabetic Association
DO  - 10.1111/dme.70277
UR  - https://doi.org/10.1111/dme.70277
ER  -

APA

RC, W., C, B., SL, G., CL, W., I, M., BT, G., E, B., D, S., MA, C., P, A., L, P., Group, B. S., AWAF, KM, G., V, L., AJK, W., & AE, L. (2026). Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.. Diabetic medicine : a journal of the British Diabetic Association. https://doi.org/10.1111/dme.70277

Source records

pubmed · retrieved 2026-09-25T01:39:33.044Z